Magnesium Demo (Magnesium Sulfate Heptahydrate)

Magnesium sulfate releases magnesium ions that act as cofactors for many enzymes, stabilize cell membranes, and antagonize calcium‑mediated processes. This reduces neuronal excitability, relaxes smooth muscle, and helps normalize cardiac electrical activity, thereby addressing the underlying electrolyte imbalance.

The dose of Magnesium Demo is individualized by the prescribing clinician based on the patient’s clinical condition, serum magnesium level, renal function, and the specific indication being treated. No fixed dosing regimen is provided in product literature.

Magnesium Demo is classified with an unknown pregnancy category. It may be used during pregnancy only when the potential benefit justifies any potential risk to the fetus, and it should be administered under close medical supervision. Limited data are available for breastfeeding.

To order Magnesium Demo, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Magnesium Demo is supplied as a sterile injectable magnesium sulfate heptahydrate solution, allowing rapid intravenous or intramuscular delivery. Compared with oral magnesium salts, it achieves higher serum concentrations more quickly, which is essential for acute correction of severe deficiency, eclampsia management, or arrhythmia control.

Magnesium Demo must be stored at 2‑8 °C in a refrigerator, protected from light, and must not be frozen or shaken. Before use, inspect the vial for particulate matter or discoloration and allow it to reach room temperature if required for administration.

Magnesium Demo is administered by a qualified healthcare professional via intramuscular or intravenous injection. The route, rate of infusion, and total dose are determined by the prescriber according to the therapeutic indication and patient-specific factors.

Serious adverse events include respiratory depression, severe hypotension, cardiac arrest, hypermagnesemia leading to neuromuscular weakness, life‑threatening arrhythmias, and anaphylactic reactions. Prompt monitoring of vital signs and serum magnesium levels is essential during and after administration.

Magnesium Demo should be avoided in patients with known hypersensitivity to magnesium sulfate, severe renal impairment where magnesium clearance is compromised, and in those receiving high doses of other magnesium‑containing products unless closely monitored.